English | 简体中文 | 繁體中文 | 한국어
Share:
Ratos AB: Invitation to Ratos's Capital Markets Day 2018

Press release 16 April 2018 

Ratos welcomes representatives from the financial markets and media to our Capital Markets Day in Stockholm on Monday 4 June 2018, starting at 13.30 p.m. and ending at approximately 17.00 p.m.

The purpose of the Capital Markets Day is to present Ratos and our subsidiaries. Speakers include Ratos's CEO Jonas Wiström, Plantasjen's CEO Daniel Juhlin, Bisnode's CEO Magnus Silfverberg and HENT's CEO Jan Jahren.

Venue: Moderna Museet, Stockholm

Attendance: If you would like to attend Ratos's Capital Markets Day, please register via this link no later than 25 May 2018.

Welcome!

For further information, please contact:
Helene Gustafsson, Head of IR & Press, +46 8 700 17 98 or helene.gustafsson@ratos.se


Financial calendar from Ratos:
Interim report January-March 2018                3 May 2018
Annual General Meeting 2018                       3 May 2018
Interim report January-June 2018                  17 August 2018
Interim report January-September 2018         25 October 2018


Ratos is an investment company that owns and develops unlisted medium-sized Nordic companies. Our goal as an active owner is to contribute to the long-term and sustainable business development in the companies we invest in and to make value-generating transactions. Ratos's portfolio consists of 13 medium-sized Nordic companies and the largest segments in terms of sales are Industrials, Construction and Consumer goods/retail. Ratos is listed on Nasdaq Stockholm and has a total of approximately 12,700 employees.




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Ratos via Globenewswire

Copyright © Thomson Reuters 2018. All rights reserved.
Press Releases
Orion to sell its Orion Diagnostica division - Due to the transaction Orion updates its outlook  
Apr 21, 2018 00:30 ET
Helsinn Group announces the FDA approval of the IV formulation of AKYNZEO® (fosnetupitant/ palonosetron) in the United States  
Apr 20, 2018 21:33 ET
BOURBON: Positive progress in negotiations with lenders  
Apr 20, 2018 18:30 ET
Hubbell Incorporated Declares Regular Quarterly Dividend  
Apr 20, 2018 16:01 ET
Helsinn Group announces the FDA approval of the IV formulation of AKYNZEO® (fosnetupitant/ palonosetron) in the United States  
Apr 20, 2018 15:23 ET
Heineken Holding N.V. - Amendments to the Articles of Association  
Apr 20, 2018 15:18 ET
Lubrizol Presents Estane® TPU and Other Innovations for Consumer, Industrial, Footwear and Electronics Applications at Chinaplas 2018  
Apr 20, 2018 12:03 ET
Lipotec Active Ingredients Becomes Umbrella Brand  
Apr 19, 2018 23:43 ET
LEH PHARMA LTD.: Company Update  
Apr 18, 2018 19:34 ET
Tusk Therapeutics presents data on to its anti-CD25 programme at AACR Annual Meeting 2018  
Apr 18, 2018 19:33 ET
More News >>
Copyright © 2018 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: